Effective Options for Oxycontin Addiction

May 1, 2013

The pharmaceutical industry has long understood the overzealous use of Oxycontin. Yet, despite the predictability, physicians have not become more cautious in prescribing these opiates. Opiate addiction is different for everyone. Some addicts can easily beat their dependency, yet for many others it’s very difficult to treat. This is because various individuals build up a […]

Read the full article →

Oxycontin Dependency: Getting Treatment

April 15, 2013
Thumbnail image for Oxycontin Dependency: Getting Treatment

A drug addiction is an incredibly challenging problem to deal with. Most people do not plan to get hooked on drugs and instead they start for reasons of personal pleasure. Over time, the body becomes addicted to the drug and you start to feel sick when you are not on the drug. When you start […]

Read the full article →

The Dangers of Oxycontin Addiction

March 31, 2013
Thumbnail image for The Dangers of Oxycontin Addiction

The dangers of prescription pain relievers cannot be overlooked. With more and more people becoming addicted to these prescription pills all the time, it only makes sense to make yourself more aware of the situation and how to avoid it. Oxycontin is one of the most common prescription drugs people become addicted to, largely due […]

Read the full article →

PMO Launches New Suboxone ® Medication AssistedTreatment Plus…

March 1, 2013

PMO Care announces implementation of Suboxone and Vivitrol Medication Assisted Treatment in conjunction with on-site counseling for…(PRWeb February 27, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10470251.htm (Source: PRWeb: Medical Pharmaceuticals) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Read the full article →

Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment.

February 28, 2013

Conclusion: The addition of raltegravir to stabilized patients receiving buprenorphine/naloxone does not significantly affect buprenorphine/naloxone or raltegravir pharmacokinetic or pharmacodynamic parameters. PMID: 23421567 [PubMed – in process] (Source: The American Journal of Drug and Alcohol Abuse) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the […]

Read the full article →

Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment.

February 28, 2013

Conclusion: The addition of raltegravir to stabilized patients receiving buprenorphine/naloxone does not significantly affect buprenorphine/naloxone or raltegravir pharmacokinetic or pharmacodynamic parameters. PMID: 23421567 [PubMed – in process] (Source: The American Journal of Drug and Alcohol Abuse) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the […]

Read the full article →

BUPRENORPHINE HCL AND NALOXONE HCL (Buprenorphine And Naloxone) Tablet [Amneal Pharmaceuticals]

February 27, 2013

Updated Date: Feb 25, 2013 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Read the full article →

Reckitt Benckiser hit by generic ruling

February 27, 2013

US Food and Drug Administration gives the go-ahead for two manufacturers to produce generic version of its highly profitable drug Suboxone (Source: FT.com – Drugs and Healthcare)

Read the full article →

FDA Approves Generic Suboxone

February 27, 2013

Feb. 25, 2013 — The United States Food and Drug Administration (FDA) has approved generic versions of Reckitt Benckiser Healthcare’s Suboxone sublingual tablets. Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg… (Source: Drugs.com – Pharma News)

Read the full article →

FDA Permits Production Of Generic Heroin Drug Against Bid Of Reckitt

February 27, 2013

Two generic forms of Reckitt Benckiser’s heroin addiction medication have been approved by U.S. regulators, rejecting the company’s bid to prevent rival products based on their belief that stricter regulations were needed on packages to better protect children. Reckitt Benckiser, a British consumer health products company, makes a good portion of its earnings from Suboxone, […]

Read the full article →

← Previous Entries

Next Entries →